Single-Ascending Doses of 2-Methoxyestradiol in Healthy Non-Pregnant Female Subjects.
This research is looking at a new medicine called 2-Methoxyestradiol. It's an early-stage study, meaning we're giving it to healthy women for the very first time to see how it works in the human body. We want to understand if it's safe and what happens when different small amounts are given. This type of study helps doctors learn more about potential new medicines before they can be used to treat specific health problems. Participants will be healthy, non-pregnant women aged 18 and over. This is a crucial first step in discovering new ways to improve health, even though this particular study isn't focused on treating an existing illness.
At a glance
What is this study about?
Imagine a brand new medicine that has never been given to people before. This study is the very first step in testing such a medicine, called 2-Methoxyestradiol, in humans. We call this a 'First-in-Human' study. The main goal is to check how safe it is and how the body handles it. We'll be giving very small, carefully controlled amounts of the medicine to healthy women to see if there are any side effects and how the medicine moves through and out of the body.
This kind of research is really important because it tells scientists whether a new medicine is safe enough to be studied further as a possible treatment for various health conditions in the future. It’s like testing a new ingredient in a recipe — you want to make sure it’s safe and you understand what it does before you try to bake a whole cake with it. Healthy volunteers are essential for this initial safety check.
Even though this study doesn't aim to treat a specific illness, the information we gather is vital. It helps researchers decide if 2-Methoxyestradiol has the potential to become a useful medicine one day, possibly for conditions that are currently hard to treat. Without these initial safety studies, new treatments could not be developed.
Key takeaways
- It's a very early study of a new medicine in healthy women.
- The main goal is to check safety and how the body handles the medicine.
- Participants must be healthy, non-pregnant women aged 18 or over.
- There's no direct personal health benefit, but it helps future medical research.
- You'll be closely monitored during your participation.
Who may be eligible?
This study is looking for healthy women to take part. To join, you must be at least 18 years old. There's no upper age limit, but you need to be generally healthy and not pregnant.
Because this is an early study to check safety, you cannot have any ongoing medical conditions that would make it unsafe to take this new medicine. The research team will carefully check your health to make sure you fit all the requirements.
Basically, if you are a non-pregnant woman aged 18 or older and in good general health, you might be able to participate. The study team will review your medical history and do some tests to confirm you're a good fit.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you a woman?
- Are you 18 years old or older?
- Are you generally healthy, without any known medical conditions?
- Are you not pregnant?
- Are you willing to follow study instructions and attend all appointments?
What does participation involve?
If you decide to take part, you would receive the new medicine, 2-Methoxyestradiol. This study is designed to test single, increasing doses, meaning different groups of participants will receive different, but carefully controlled, single doses of the medicine. You would likely have several visits to a clinic or hospital for check-ups, blood tests, and to receive the medication. The research team will monitor you closely after you take the medicine to see how your body reacts.
The number of visits and the total time involved can vary depending on the study details, but these studies usually involve a short stay at a clinic for initial monitoring after receiving the dose, followed by a few follow-up appointments. Throughout your participation, you'll have regular medical checks and tests to ensure your safety. The total duration of your involvement, from your first visit to your last follow-up, will be clearly explained by the study team.
Potential risks and benefits
Locations (1)
- —UnverifiedPortugal
Common questions
What is 2-Methoxyestradiol?
It's a new medicine being tested for the very first time in people. Its potential uses are being explored in future studies.
Will this study help my existing health problems?
No, this study is not designed to treat any health conditions. It's focused on checking the safety of a new medicine in healthy people.
How long will I need to be involved?
The exact duration will be explained by the study team, but typically these studies involve several clinic visits over a few weeks or months.
Do I have to pay to participate?
No, you should never have to pay to participate in a clinical trial. Sometimes you might receive payment for your time and travel.
What if I experience side effects?
The study team will monitor you closely for any side effects and provide care. You can also withdraw from the study at any time.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.